Clara’s administrative badge, usually a symbol of corporate access, became our key to a different kind of vault. The medical records repository at St. Jude’s Hospital was a labyrinth of dimly lit aisles and towering shelves, each holding decades of lives reduced to paper and digital files. The air was cool and smelled faintly of old paper and sterile disinfectant.
“Box 408,” Clara murmured, her voice echoing slightly in the vast space. She pointed to a shelf high above us. “That’s Dad’s hospice archive.”
A records clerk, a kind-faced woman with tired eyes, helped us retrieve the heavy cardboard box. We carried it to a small, private viewing room, where a single lamp cast a circle of yellow light on a metal table.
Clara carefully opened the box. Inside, among stacks of faded medical charts and nursing notes from 2018, was a thick, sealed envelope. It was stamped with an urgent red ledger mark, indicating it held critical information.
“This is it,” Clara breathed, her fingers tracing the red stamp.
She tore open the seal. Inside, nested in a padded compartment, was a small, silver hardware key, identical in size and shape to the flash drive I carried. It wasn’t just a key; it was a physical encryption token.
My hands trembled as I took it. I pulled my laptop from the leather briefcase, setting it on the table. The screen glowed in the dim room.
I plugged in the hardware key, then the flash drive. The laptop whirred, its fan kicking into a higher gear. A progress bar appeared, slowly filling. Seconds stretched into an eternity.
Then, a new folder appeared on the screen, bursting with documents. Four thousand pages. Phase III pharmaceutical trial data.
My eyes scanned the file names, then the first few lines of a patient log. The names were anonymous, numbers mostly, but the details were stark.
“Patient 72-A,” I read aloud, my voice flat. “Organ failure. Cause of death: acute renal toxicity.”
Clara leaned closer, her finger moving down the screen. “And Patient 76-C… hepatic encephalopathy. Patient 81-F… severe cardiac arrest. All during the initial authorization window.”
Eight names. Eight trial subjects, all suffering fatal organ toxicity, not from their underlying conditions, but from the experimental drug Aldridge BioHealth had launched. The drug that had made Julian a multi-millionaire.
A wave of nausea washed over me. The cold clinical details on the screen chilled me far more than the repository’s temperature. My son’s empire was built on this. On these lives.
My heart began to pound, a frantic drum against my ribs, echoing the whirring of the hard drive.
+ There are no comments
Add yours